Epstein Secrets

tein. Mark Note Type: ID Event Department: Identifications Date77me: 08/11/2019 09:56 Entered By: Notes: Dr. S presented to our office with the Decedent's brother to watch the autopsy. He was given an observer form to complete and was swabbed before he went to observe the autopsy Note Type: Status M

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5

No U '36 f t i C Hospital in.pstient I-Capita/ ED/ ail:patient Hasp WA Other, specify: U U U Nursing hcene/long wan ewe Hospice facility Decedent's residence DATE AND HOUR OF DEATH: 08/10/2019 7:36 AM Jnk INJURY: Cote Time: AN PM AT wOR< YES _ NO TYPE OF PLACE:IN:me, Stmet, etc./ L

ynthetic Cannabinotds Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for aaranstuad Ret Limit COOMBS' Rot—Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/m

Epstein, Mark Note Type: ID Even Department: Identifications Detonate: 08/1112019 09:58 Entered By: Notes: Dr. resented to our office with the Decedent's brother to watch the autopsy. He was given an observer form to complete an was swabbed before he went to observe the autopsy Note Type: Status Ma

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for Compound Rid I iat C.00.12011XL Rot Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 n